The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women
Open accessAbstract
Purpose: To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women. Patients and Methods: This multicenter prospective study was carried out at 16 institutions in Japan. Twenty-eight patients having EC at presumed stage IA and 17 patients with AH at younger than 40 years of age were enrolled. All patients were given a daily oral dose of 600 mg of MPA with low-dose aspirin. This treatment continued for 26 weeks, as long as the patients responded. Histologic change of endometrial tissue was assessed at 8 and 16 weeks of treatment. Either estrogen-progestin therapy or fertility treatment was provided for the responders after MPA therapy. The primary end point was a pathologic complete response (CR) rate. Toxicity, pregnancy rate, and progression-free interval were secondary end points. Results: CR was found in 55% of EC cases and 82% of AH cases. The overall CR rate was 67%. Neither therapeutic death nor irreversible toxicities were observed; however, two patients had grade 3 body weight gain, and one patient had grade 3 liver dysfunction. During the 3-year follow-up period, 12 pregnancies and seven normal deliveries were achieved after MPA therapy. Fourteen recurrences were found in 30 patients (47%) between 7 and 36 months. Conclusion: The efficacy of fertility-sparing treatment with a high-dose of MPA for EC and AH was proven by this prospective trial. Even in responders, however, close follow-up is required because of the substantial rate of recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study
Creasman, W. T., Morrow, C. P., Bundy, B. N., Homesley, H. D., Graham, J. E., & Heller, P. B. (1987) · Cancer · doi:10.1002/1097-0142(19901015)60:8+<2035::aid-cncr2820601515>3.0.co;2-8 · Cited by 1,963
Kurman, R. J., Kaminski, P. F., & Norris, H. J. (1985) · Cancer · doi:10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x · Cited by 1,252
Trimble, C. L., Kauderer, J., Zaino, R., Silverberg, S., Lim, P. C., Burke, J. J., Alberts, D., & Curtin, J. (2006) · Cancer · doi:10.1002/cncr.21650 · Cited by 601
Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.
Boronow, R. C., Morrow, C. P., Creasman, W. T., DiSaia, P. J., Silverberg, S. G., Miller, A., & Blessing, J. A. (1984) · PubMed · Cited by 589
RANDALL, T., & KURMAN, R. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00297-4 · Cited by 425
Adenocarcinoma of the endometrium in women 40 years of age or younger.
GALLUP, D. G., & Stock, R. J. (1984) · PubMed · Cited by 319
Kim, Y. B., Holschneider, C. H., Ghosh, K., Nieberg, R. K., & Montz, F. J. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970115)79:2<320::aid-cncr15>3.0.co;2-2 · Cited by 259
Kaku, T., Yoshikawa, H., Tsuda, H., Sakamoto, A., Fukunaga, M., Kuwabara, Y., Hataeg, M., Kodama, S., Kuzuya, K., Sato, S., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00462-1 · Cited by 242
Self-citationJadoul, P., & Donnez, J. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01183-x · Cited by 131
Regression of Latent Endometrial Precancers by Progestin Infiltrated Intrauterine Device
Ørbo, A., Rise, C. E., & Mutter, G. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4321 · Cited by 44
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., González-Martín, A., Ledermann, J., Marth, C., Nout, R., Querleu, D., Mirza, M. R., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv484 · Cited by 1,386
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., Gonzalez-Martin, A., Ledermann, J., Marth, C., Nout, R., Querleu, D., Mirza, M. R., et al. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000609 · Cited by 767
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Koh, W.-J., Abu-Rustum, N. R., Bean, S., Bradley, K., Campos, S. M., Cho, K. R., Chon, H. S., Chu, C., Cohn, D., Crispens, M. A., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0006 · Cited by 643
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Abu-Rustum, N., Yashar, C., Arend, R., Barber, E., Bradley, K., Brooks, R., Campos, S. M., Chino, J., Chon, H. S., Chu, C., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.0006 · Cited by 568
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Gunderson, C. C., Fader, A. N., Carson, K. A., & Bristow, R. E. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.01.003 · Cited by 463
Endometrial cancer: A review and current management strategies: Part II
Burke, W. M., Orr, J., Leitao, M., Salom, E., Gehrig, P., Olawaiye, A. B., Brewer, M., Boruta, D., Herzog, T. J., & Shahin, F. A. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.003 · Cited by 459
Gallos, I. D., Yap, J., Rajkhowa, M., Luesley, D. M., Coomarasamy, A., & Gupta, J. K. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.011 · Cited by 382
Sorosky, J. I. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182605bf1 · Cited by 332
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003072 · Cited by 147
Metadata
- Authors
- Ushijima, K., Yahata, H., Yoshikawa, H., Konishi, I., Yasugi, T., Saito, T., Nakanishi, T., Sasaki, H., Saji, F., Iwasaka, T., Hatae, M., Kodama, S., Saito, T., Terakawa, N., Yaegashi, N., Hiura, M., Sakamoto, A., Tsuda, H., Fukunaga, M., & Kamura, T.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-07-01
- Volume
- 25
- Issue
- 19
- Pages
- 2798-2803
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2146896519
- Cited by
- 412
- References
- 10
- FWCI
- 19.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.